Interferon Sciences plans to study Alferon N for MS, is in clinicals for HIV.
Executive Summary
INTERFERON SCIENCES WILL TEST INTERFERON ALFA-N3 FOR MULTIPLE SCLEROSIS "once sufficient funding has been obtained," the New Brunswick, N.J.-based biotech reported in its recently-released 1994 annual report. Interferon Sciences, Inc. cited "significant adverse reactions" with Chiron/Berlex' Betaseron for relapsing-remitting multiple sclerosis as a factor in the decision to study its natural-source, human leukocyte-derived alpha interferon for the disease. ISI is the only manufacturer of natural source alpha interferon in the U.S.